Upgrade to SI Premium - Free Trial

Axsome Therapeutics (AXSM) PT Lowered to $279 at RBC Capital

August 11, 2026 7:57 AM
(Updated - August 11, 2026 10:01 AM EDT)

RBC Capital analyst Leonid Timashev lowered the price target on Axsome ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change